T 1741/22 (New medical data/ROCHE) of 26.07.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T174122.20240726
- Date of decision
- 26 July 2024
- Case number
- T 1741/22
- Online on
- 18 September 2024
- Petition for review of
- -
- Application number
- 16153964.8
- IPC class
- G06F 19/00
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen and members (B)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 Art 056
- Application title
- System and method for analyzing glucose monitoring data indicative of a glucose level, and a computer program product
- Applicant name
- Roche Diabetes Care GmbH
F. Hoffmann-La Roche AG - Opponent name
- -
- Board
- 3.5.05
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 84European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 020(1)Rules of procedure of the Boards of Appeal 2020 Art 020(2)Guidelines_Part G, Chapter II, 3(3)
- Keywords
- Claims - clarity (no)
Inventive step - (no): no credible technical effect produced by deriving additional data from medical measurements - Catchword
- The mere generation of further data from measurement data already collected from the human body is not a technical effect (T
2681/16 and the Guidelines for Examination not followed). See Reasons 2.3 of the decision. - Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.